Trial · NCT02064166
Results by group24
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 24
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Verbal Fluency FAS (F, A or S Words) Total Score | Insulin Baseline | 38.8 | Standard Deviation 5.7 | Words | |
| Change in Verbal Fluency FAS (F, A or S Words) Total Score | Insulin Post Treatment | 41.0 | Standard Deviation 8.2 | Words | |
| Change in Verbal Fluency FAS (F, A or S Words) Total Score | Placebo Baseline | 32.8 | Standard Deviation 2.3 | Words | |
| Change in Verbal Fluency FAS (F, A or S Words) Total Score | Placebo Post Treatment | 30.8 | Standard Deviation 7.1 | Words | |
| Modified Hoehn and Yahr Scale | Insulin Baseline | 2.0 | Standard Deviation 0.6 | score on a scale | |
| Modified Hoehn and Yahr Scale | Insulin Post Treatment | 2.0 | Standard Deviation 0.7 | score on a scale | |
| Modified Hoehn and Yahr Scale | Placebo Baseline | 2.4 | Standard Deviation 0.38 | score on a scale | |
| Modified Hoehn and Yahr Scale | Placebo Post Treatment | 2.4 | Standard Deviation 0.2 | score on a scale | |
| Cognitive Impairment Using Montreal Cognitive Assessment (MoCA) | Insulin Baseline | 28.7 | Standard Deviation 1.2 | score on a scale | |
| Cognitive Impairment Using Montreal Cognitive Assessment (MoCA) | Insulin Post Treatment | 28.0 | Standard Deviation 1.1 | score on a scale | |
| Cognitive Impairment Using Montreal Cognitive Assessment (MoCA) | Placebo Baseline | 26.8 | Standard Deviation 2.6 | score on a scale | |
| Cognitive Impairment Using Montreal Cognitive Assessment (MoCA) | Placebo Post Treatment | 28.2 | Standard Deviation 0.95 | score on a scale | |
| Beck Depression Inventory Score (BDI) | Insulin Baseline | 7.8 | Standard Deviation 5.4 | score on a scale | |
| Beck Depression Inventory Score (BDI) | Insulin Post Treatment | 8.25 | Standard Deviation 8.1 | score on a scale | |
| Beck Depression Inventory Score (BDI) | Placebo Baseline | 13.5 | Standard Deviation 5.6 | score on a scale | |
| Beck Depression Inventory Score (BDI) | Placebo Post Treatment | 12.8 | Standard Deviation 7.4 | score on a scale | |
| Unified Parkinson's Disease Rating Scale Part III (UPDRS Part III) | Insulin Baseline | 31.5 | Standard Deviation 20.0 | score on a scale | |
| Unified Parkinson's Disease Rating Scale Part III (UPDRS Part III) | Insulin Post Treatment | 25.6 | Standard Deviation 21.8 | score on a scale | |
| Unified Parkinson's Disease Rating Scale Part III (UPDRS Part III) | Placebo Baseline | 31.7 | Standard Deviation 13.3 | score on a scale | |
| Unified Parkinson's Disease Rating Scale Part III (UPDRS Part III) | Placebo Post Treatment | 30.5 | Standard Deviation 15.8 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02064166/results